|
|
|
|
Sinus Relief by BHI helps relieve nasal congestion, sinus
headache and pressure and cold/flu nasal symptoms.
• Promotes relief from such nasal symptoms as congestion, headaches and sinus
pressure.
• Helps to relieve the facial pain and pressure caused by colds, flu and nasal
rhinitis.
• Active plants and minerals: Combining 4 plants like Euphorbium officinarum
and Hydrastis with 3 active mineral ingredients for targeted sinus symptom
relief. Does not cause drowsiness, over-dryness or jitters.
• Homeopathic approach: Homeopathy treats symptoms with a micro-dose of an
active ingredient to stimulate the body’s own defenses. MediNatura's approach
combines multiple potent actives, in multiple concentrations for greater relief
of more symptoms.
• Safe, effective relief: All BHI tablets have no known interactions with other
medicines or supplements and are non-addictive.
• Quick dissolve tablets: Easy to use, dissolvable tablets for fast, convenient
relief whenever symptoms start. This safe formula can be taken daily, or as
needed during symptom flare ups.
Sinus Relief Ingredients in 1 tablet:
*Euphorbium officinarum 6X, *Hydrastis canadensis 6X, Kali bichromicum 6X, Kali
iodatum 8X, *Phosphorus 8X, *Pulsatilla 4X, *Thuja occidentalis 6X 42.9 mg
each. Inactive Ingredients: Lactose, Magnesium stearate.
*Natural Ingredients X is a homeopathic dilution
Suggested Use: At first sign of symptoms: Adults and children 4 years and older: 1 tablet
every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage.
Do not exceed 12 tablets in 24 hours. Standard dosage: Adults and children 4 years and older: 3 tablets per day,
taking 1 tablet every 4 to 6 hours. For children under 4, consult your health professional. Allow tablets to
dissolve completely in the mouth, do not swallow.
Consult your healthcare practitioner prior to using this product if you are
pregnant, nursing or if symptoms persist or worsen. Do not use if known
sensitivity to Sinus or any of its ingredients exists.
Keep out of reach of children.
|
|
|
|
|
|
|